Antiepileptic Drug Selection for Partial-Onset Seizures
- First Online:
Effective treatment of seizures resulting from epilepsy relies on several basic principles, regardless of which drug or treatment is selected. Treatment starts with a confident diagnosis that the symptoms are, indeed, seizure. The seizure type should be classified as focal in onset or primary generalized, and there should be a relentless search for the etiology. Many antiepileptic drugs (AEDs) are available to treat partial-onset seizures. Given that the efficacy of AEDs is comparable, selection of the appropriate drug is mostly determined by whether any comorbidities are present, such as migraine, obesity, depression, or chronic pain. In the absence of comorbidities, it depends on the side effect profile, cost, and convenience. Most AEDs, with a few exceptions, must be increased to a maximum tolerated dose before a second drug should be added. Most patients can become seizure free or adequately controlled if continued interventions are considered at each encounter until patients are seizure free.
KeywordsAntiepileptic drugs AEDs Seizures Selection Partial onset Pharmacologic Epilepsy Seizure disorder Focal seizures Treatment Diet Surgery Vagus nerve stimulation Deep brain stimulation Responsive neurostimulation
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 4.Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies. Epilepsia. 2010;51:676–85.Google Scholar
- 8.NIH Conference. “Curing Epilepsy: Hope for the Future.” Web address: http://www.ninds.nih.gov/news_and_events/conference_curing_epilepsy_summary.htm.
- 9.Fountain NB. Choosing Among Antiepileptic Drugs. Continuum: Lifelong Learning in Neurology. 2010;16(3):121–35.Google Scholar
- 10.French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1252–60.PubMedCrossRefGoogle Scholar
- 11.French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1261–73.PubMedCrossRefGoogle Scholar
- 12.Harden CL, Meador KJ, Pennell PB, et al. Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73:133–41.PubMedCrossRefGoogle Scholar
- 14.Engel J, Wiebe Jr S, French J, et al. Practice parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology. 2003;60:538–47.PubMedCrossRefGoogle Scholar
- 17.Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever Jr CT. For the American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association–Convened Physician Consortium for Performance Improvement Independent Measure Development Process. Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2011;76(1):94–9.PubMedCrossRefGoogle Scholar
- 24.Fountain NB. Manual of Antiepileptic Drug Therapy. West Islip: Professional Publications, Inc; 2010.Google Scholar